cyclohexanol has been researched along with buspirone in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (16.00) | 18.2507 |
| 2000's | 15 (60.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duman, RS; Heninger, GR; Malison, RT; Nestler, EJ; Price, LH | 1 |
| Davidson, JR; DuPont, RL; Haskins, JT; Hedges, D | 1 |
| Ninan, PT | 1 |
| Sheehan, DV | 1 |
| Gunning, K; Magill, MK | 1 |
| Woods, SW | 1 |
| Ballenger, JC | 1 |
| Brault, Y; Hackett, D; Meoni, P; Salinas, E | 1 |
| Gorman, JM | 2 |
| Burton, D; Camilleri, M; Chial, HJ; Olden, KW; Stephens, D; Thomforde, G | 1 |
| Sternbach, H | 1 |
| Rickels, K; Rynn, M | 1 |
| Gupta, S; Masand, PS | 1 |
| Al-Khalili, M; Meidan, VM; Michniak, BB | 1 |
| Burton, D; Camilleri, M; Chial, HJ; Delgado-Aros, S; Ferber, I; McKinzie, S; Zinsmeister, AR | 1 |
| Pavlovic, ZM | 1 |
| Biggs, MM; Fava, M; Friedman, ES; Hollon, SD; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Rush, AJ; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Caykoylu, A; Ekinci, O; Kuloglu, M | 1 |
| Laje, G; McMahon, FJ; Perlis, RH; Rush, AJ | 1 |
| Dusetzina, SB; Ellis, AR; Farley, JF; Gaynes, BN; Hansen, RA; Miller, WC; Stürmer, T | 2 |
| Fava, M; Perlis, RH; Perroud, N; Uher, R | 1 |
| Cao, L; Chen, J; Fang, Y; Hong, W; Peng, D; Wu, Z; Yuan, C; Zhang, C | 1 |
| Bijlsma, EY; Chan, JS; Millan, MJ; Olivier, B; Oosting, RS; Veening, JG; Waldinger, MD | 1 |
10 review(s) available for cyclohexanol and buspirone
| Article | Year |
|---|---|
The functional anatomy, neurochemistry, and pharmacology of anxiety.
Topics: Adrenergic Uptake Inhibitors; Amygdala; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clomipramine; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Norepinephrine; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 1999 |
Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1999 |
Pharmacoeconomic studies of antidepressants: focus on venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Buspirone; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Drug Tolerance; Fluoxetine; Fluvoxamine; Humans; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Cyclohexanols; Drug Administration Schedule; gamma-Aminobutyric Acid; Humans; Monoamine Oxidase Inhibitors; Norepinephrine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Treatment of generalized anxiety disorder.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Cognitive Behavioral Therapy; Cyclohexanols; Follow-Up Studies; Humans; Paroxetine; Psychotherapy; Pyrimidines; Relaxation Therapy; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Pharmacotherapy of generalized anxiety disorder.
Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Paroxetine; Psychotherapeutic Processes; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Treating generalized anxiety disorder.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Cognitive Behavioral Therapy; Cyclohexanols; Humans; Imipramine; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2003 |
The safety of SSRIs in generalised anxiety disorder: any reason to be anxious?
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Cyclohexanols; Humans; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 2003 |
Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release?
Topics: Animals; Antidepressive Agents; Aza Compounds; Brain; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Buspirone; Cyclohexanols; Disease Models, Animal; Dopamine; Female; Humans; Indoles; Male; Norepinephrine; Paroxetine; Pyridines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Sexual Behavior, Animal; Sexual Dysfunction, Physiological; Synaptic Transmission; Venlafaxine Hydrochloride | 2014 |
8 trial(s) available for cyclohexanol and buspirone
| Article | Year |
|---|---|
Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Buspirone; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health.
Topics: Adult; Buspirone; Colon; Cyclohexanols; Double-Blind Method; Fasting; Female; Gastric Emptying; Gastrointestinal Motility; Humans; Male; Middle Aged; Paroxetine; Postprandial Period; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Tomography, Emission-Computed, Single-Photon; Venlafaxine Hydrochloride | 2003 |
Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Buspirone; Colon; Compliance; Cyclohexanols; Double-Blind Method; Fasting; Female; Humans; Male; Pain; Postprandial Period; Pressure; Reference Values; Selective Serotonin Reuptake Inhibitors; Sensory Thresholds; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 2003 |
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cross-Over Studies; Cyclohexanols; Decision Trees; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Pharmacogenetics studies in STAR*D: strengths, limitations, and results.
Topics: Adult; Biomarkers; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Humans; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Receptors, Kainic Acid; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Humans; Likelihood Functions; Male; Middle Aged; Personality Inventory; Psychometrics; Quality of Life; Sertraline; United States; Venlafaxine Hydrochloride; Young Adult | 2012 |
Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Buspirone; China; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Remission Induction; Risperidone; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
8 other study(ies) available for cyclohexanol and buspirone
| Article | Year |
|---|---|
Efficacy of papaverine addition for treatment-refractory major depression.
Topics: Buspirone; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lithium; Middle Aged; Papaverine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Generalized anxiety disorder in family practice patients.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Cyclohexanols; Depression; Diagnosis, Differential; Family Practice; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; United States; Venlafaxine Hydrochloride | 2000 |
Venlafaxine-induced galactorrhea.
Topics: Adult; Antidepressive Agents, Second-Generation; Buspirone; Cyclohexanols; Female; Galactorrhea; Humans; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 2003 |
Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers.
Topics: Adjuvants, Pharmaceutic; Administration, Cutaneous; Anti-Anxiety Agents; Azepines; Buspirone; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cyclohexane Monoterpenes; Cyclohexanols; Cyclohexenes; Eucalyptol; Humans; In Vitro Techniques; Iontophoresis; Menthol; Monoterpenes; Oleic Acid; Skin; Skin Absorption; Time Factors | 2003 |
Buspirone to improve compliance in venlafaxine-induced movement disorder.
Topics: Antidepressive Agents, Second-Generation; Buspirone; Compliance; Cyclohexanols; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 2004 |
Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone.
Topics: Adult; Antidepressive Agents, Second-Generation; Buspirone; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Severity of Illness Index; Sleep Bruxism; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
Topics: Adult; Bias; Bupropion; Buspirone; Cluster Analysis; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Intention; Male; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Personality Inventory; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Sertraline; Suicidal Ideation; Suicide, Attempted; Thinking; Venlafaxine Hydrochloride | 2012 |